164 related articles for article (PubMed ID: 11443176)
1. Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis.
Nørrelund H; Møller N; Nair KS; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2001 Jul; 86(7):3120-9. PubMed ID: 11443176
[TBL] [Abstract][Full Text] [Related]
2. The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults.
Nielsen S; Møller N; Pedersen SB; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2002 Jul; 87(7):3274-8. PubMed ID: 12107236
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
[TBL] [Abstract][Full Text] [Related]
4. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
[TBL] [Abstract][Full Text] [Related]
5. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
Nørrelund H; Vahl N; Juul A; Møller N; Alberti KG; Skakkebaek NE; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
[TBL] [Abstract][Full Text] [Related]
6. Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients.
Nørrelund H; Djurhuus C; Jørgensen JO; Nielsen S; Nair KS; Schmitz O; Christiansen JS; Møller N
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E737-43. PubMed ID: 12799313
[TBL] [Abstract][Full Text] [Related]
7. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
[TBL] [Abstract][Full Text] [Related]
8. Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men.
Kanaley JA; Dall R; Møller N; Nielsen SC; Christiansen JS; Jensen MD; Jørgensen JO
J Appl Physiol (1985); 2004 Feb; 96(2):747-53. PubMed ID: 14594860
[TBL] [Abstract][Full Text] [Related]
9. Effects of morning cortisol replacement on glucose and lipid metabolism in GH-treated subjects.
Segerlantz M; Bramnert M; Thomasson R; Manhem P; Laurila E; Groop LC
Eur J Endocrinol; 2004 Dec; 151(6):701-7. PubMed ID: 15588236
[TBL] [Abstract][Full Text] [Related]
10. The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown.
Nørrelund H; Nair KS; Jørgensen JO; Christiansen JS; Møller N
Diabetes; 2001 Jan; 50(1):96-104. PubMed ID: 11147801
[TBL] [Abstract][Full Text] [Related]
11. The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients.
Kousta E; Chrisoulidou A; Lawrence NJ; Anyaoku V; Al-Shoumer KA; Johnston DG
Clin Endocrinol (Oxf); 2000 Jan; 52(1):17-24. PubMed ID: 10651749
[TBL] [Abstract][Full Text] [Related]
12. The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.
Nørrelund H; Nair KS; Nielsen S; Frystyk J; Ivarsen P; Jørgensen JO; Christiansen JS; Møller N
J Clin Endocrinol Metab; 2003 Sep; 88(9):4371-8. PubMed ID: 12970312
[TBL] [Abstract][Full Text] [Related]
13. Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
Nørrelund H; Nielsen S; Christiansen JS; Jørgensen JO; Møller N
Eur J Endocrinol; 2004 Jun; 150(6):779-87. PubMed ID: 15191347
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.
Mauras N; O'Brien KO; Welch S; Rini A; Helgeson K; Vieira NE; Yergey AL
J Clin Endocrinol Metab; 2000 Apr; 85(4):1686-94. PubMed ID: 10770216
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults.
Krusenstjerna-Hafstrøm T; Clasen BF; Møller N; Jessen N; Pedersen SB; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2011 Aug; 96(8):2548-57. PubMed ID: 21613350
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients.
Toogood AA; Taylor NF; Shalet SM; Monson JP
J Clin Endocrinol Metab; 2000 Apr; 85(4):1727-30. PubMed ID: 10770221
[TBL] [Abstract][Full Text] [Related]
17. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
Bramnert M; Segerlantz M; Laurila E; Daugaard JR; Manhem P; Groop L
J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
[TBL] [Abstract][Full Text] [Related]
19. Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.
Al-Shoumer KA; Ali K; Anyaoku V; Niththyananthan R; Johnston DG
Clin Endocrinol (Oxf); 1996 Aug; 45(2):171-8. PubMed ID: 8881449
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections.
Johansson JO; Wirén L; Oscarsson J; Bengtsson BA; Johannsson G
Growth Horm IGF Res; 2003 Dec; 13(6):306-15. PubMed ID: 14624763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
